LBRX

LB Pharmaceuticals
LBRX

53 hedge funds and large institutions have $315M invested in LB Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 53 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
53
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$52.9M
2
+$28.1M
3
+$27.6M
4
CC
Commodore Capital
New York
+$23.7M
5
LGM
Logos Global Management
California
+$17.8M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
DTC
1
Deep Track Capital
Connecticut
$52.9M
RCM
2
RA Capital Management
Massachusetts
$28.1M
TCM
3
TCG Crossover Management
California
$27.6M
CC
4
Commodore Capital
New York
$23.7M
LGM
5
Logos Global Management
California
$17.8M
JP Morgan Chase
6
JP Morgan Chase
New York
$16.3M
BlackRock
7
BlackRock
New York
$15.4M
Balyasny Asset Management
8
Balyasny Asset Management
Illinois
$15.3M
VC
9
Vivo Capital
California
$12.6M
Jennison Associates
10
Jennison Associates
New York
$11.7M
NCM
11
Nantahala Capital Management
Connecticut
$10.7M
Alyeska Investment Group
12
Alyeska Investment Group
Illinois
$10.7M
Citadel Advisors
13
Citadel Advisors
Florida
$8.52M
Millennium Management
14
Millennium Management
New York
$8.5M
SCM
15
Soleus Capital Management
Connecticut
$6.32M
Fidelity Investments
16
Fidelity Investments
Massachusetts
$5.83M
Wellington Management Group
17
Wellington Management Group
Massachusetts
$5.44M
Goldman Sachs
18
Goldman Sachs
New York
$5.42M
NFGH
19
Nan Fung Group Holdings
Hong Kong
$4.74M
T. Rowe Price Associates
20
T. Rowe Price Associates
Maryland
$4.46M
Marshall Wace
21
Marshall Wace
United Kingdom
$4.03M
Adage Capital Partners
22
Adage Capital Partners
Massachusetts
$3.16M
BBA
23
Baker Bros. Advisors
New York
$3.16M
IHAM
24
Integral Health Asset Management
New York
$1.58M
Ameriprise
25
Ameriprise
Minnesota
$1.22M
1
2 3